Novo Nordisk
NVO
126.72
0%
Novo Nordisk A/S engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Diseases. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark
Yahoo Finance
Download Now to Buy Novo Nordisk
Price Changes
-12.32%
1 Month
-0.12%
3 Months
57.29%
1 Year
Specs
Min Quantity
0.01 Shares
Price Quotation
USD
Leverage
1:5
Market Cap
$564.85B
EPS (TTM)
$2.89
P/E Ratio (TTM)
43.83
Dividend Yield
1.07%
Beta (5Y, Monthly)
0.15
Trading Hours (GMT)
Saturday
No Trading
Sunday
No Trading
Monday
00:00 - 00:00
Tuesday
No Trading
Wednesday
No Trading
Thursday
No Trading
Friday
No Trading
Analyst Rating
Strong Sell [1]
Sell [0]
Hold [1]
Buy [4]
Strong Buy [5]
80.4
Target Price
4.0909
Average Score
The information presented above is for informational purposes only. It should not be interpreted as a recommendation to perform actions and/or investment advice and/or any type of consultation. You may review our KID documents here